{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:59:35Z","timestamp":1780711175578,"version":"3.54.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.euo.2026.05.013","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:01:19Z","timestamp":1780632079000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sequential Imaging of Suspicion of Prostate Cancer: Reducing Overdiagnosis and Unnecessary Biopsy with Timely Diagnosis of Significant Cancer (SPROUT)\u2014Prospective Multicentre Cohort Study Protocol"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1209-5903","authenticated-orcid":false,"given":"V.","family":"Sweere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"de Rooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.M.","family":"Kil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Israel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.A.","family":"van Basten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.N.","family":"Boellaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Graus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G.","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.J.R.J.","family":"van der Hoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.S.","family":"Klaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.S.","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.","family":"Prette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.J.","family":"Roelofs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.M.","family":"Sedelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Snoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.M.","family":"Somford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.O.","family":"Barentsz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.H.E.","family":"Van Melick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.C.N.","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2026.05.013_b0005","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.eururo.2018.11.023","volume":"75","author":"van der Leest","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.05.013_b0010","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.eururo.2021.06.026","article-title":"Effects of magnetic resonance imaging targeting on overdiagnosis and overtreatment of prostate cancer","volume":"80","author":"Vickers","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.05.013_b0015","doi-asserted-by":"crossref","unstructured":"Prinsen AMA, Wagensveld IM, Osses DF, et al. Extending current guideline-recommended prostate-specific antigen density thresholds for improving benefit\/harm balance in risk-based magnetic resonance imaging\u2013directed prostate cancer diagnosis, from the community-based multicentre MR-PROPER study. Eur Urol Oncol 2025. In press. https:\/\/doi.org\/10.1016\/j.euo.2025.11.002.","DOI":"10.1016\/j.euo.2025.11.002"},{"key":"10.1016\/j.euo.2026.05.013_b0020","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.euo.2023.12.007","article-title":"Patient-reported side effects 1 year after radical prostatectomy or radiotherapy for prostate cancer: a register-based nationwide study","volume":"7","author":"Corsini","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2026.05.013_b0025","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300018","article-title":"Patient-reported outcomes 12 years after localized prostate cancer treatment","volume":"2","author":"Donovan","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1016\/j.euo.2026.05.013_b0030","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","article-title":"Long-term follow-up of a large active surveillance cohort of patients with prostate cancer","volume":"33","author":"Klotz","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2026.05.013_b0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.30233","article-title":"Frequency of biopsy and tumor grade before vs after introduction of prostate magnetic resonance imaging","volume":"6","author":"Robinson","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euo.2026.05.013_b0040","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2026.05.013_b0045","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.euo.2021.06.006","article-title":"A European model for an organised risk-stratified early detection programme for prostate cancer","volume":"4","author":"Van Poppel","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2026.05.013_b0050","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1056\/NEJMoa2209454","article-title":"Prostate cancer screening with PSA and MRI followed by targeted biopsy only","volume":"387","author":"Hugosson","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2026.05.013_b0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.21037\/tau.2017.12.31","article-title":"MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions?","volume":"7","author":"Schoots","year":"2018","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.euo.2026.05.013_b0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17260-6","article-title":"Follow-up of men with a PI-RADS 4\/5 lesion after negative MRI\/ultrasound fusion biopsy","volume":"12","author":"Kornienko","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.euo.2026.05.013_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2023.110929","article-title":"Reconciling discordance between PI-RADS 4 lesions and targeted biopsy: early experience of a multidisciplinary quality improvement protocol with PI-RADS 4 subcategorization","volume":"165","author":"Deivasigamani","year":"2023","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.euo.2026.05.013_b0070","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.euo.2020.08.014","article-title":"Combined use of prostate-specific antigen density and magnetic resonance imaging for prostate biopsy decision planning: A retrospective multi-institutional study using the prostate magnetic resonance imaging outcome database (Promod)","volume":"4","author":"Falagario","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2026.05.013_b0075","first-page":"212","article-title":"Routine systematic prostate biopsies not replaced by magnetic resonance imaging-targeted biopsy","volume":"74","author":"G\u00f3mez-Ortiz","year":"2022","journal-title":"Rev Invest Clin"},{"key":"10.1016\/j.euo.2026.05.013_b0080","doi-asserted-by":"crossref","first-page":"431.e9","DOI":"10.1016\/j.urolonc.2020.11.010","article-title":"PI-RADS 3 lesions: does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer?","volume":"39","author":"Rico","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2026.05.013_b0085","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: Screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.05.013_b0090","unstructured":"PI-RADS \u00ae v2.1 PI-RADS \u00ae Prostate Imaging-Reporting and Data System 2019 Version 2.1 PI-RADS \u00ae Prostate Imaging-Reporting and Data System. 2019 Version 2.1 n.d."},{"key":"10.1016\/j.euo.2026.05.013_b0095","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.1007\/s00330-024-10795-4","article-title":"PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI","volume":"34","author":"de Rooij","year":"2024","journal-title":"Eur Radiol"},{"key":"10.1016\/j.euo.2026.05.013_b0100","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1007\/s00330-020-06929-z","article-title":"ESUR\/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists\u2019 training","volume":"30","author":"de Rooij","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.euo.2026.05.013_b0105","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.eururo.2015.06.046","article-title":"A contemporary prostate cancer grading system: a validated alternative to the Gleason Score","volume":"69","author":"Epstein","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.05.013_b0110","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00345-020-03402-w","article-title":"Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic","volume":"39","author":"Diamand","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2026.05.013_b0115","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/JU.0000000000001601","article-title":"Systematic review of time to definitive treatment for intermediate risk and high risk prostate cancer: are delays associated with worse outcomes?","volume":"205","author":"Nguyen","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2026.05.013_b0120","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/bju.15277","article-title":"Risk\u2010adapted biopsy decision based on prostate magnetic resonance imaging and prostate\u2010specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation","volume":"127","author":"Schoots","year":"2021","journal-title":"BJU Int"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126001537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126001537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:01:29Z","timestamp":1780707689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931126001537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":24,"alternative-id":["S2588931126001537"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2026.05.013","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sequential Imaging of Suspicion of Prostate Cancer: Reducing Overdiagnosis and Unnecessary Biopsy with Timely Diagnosis of Significant Cancer (SPROUT)\u2014Prospective Multicentre Cohort Study Protocol","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2026.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}